Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_assertion type Assertion NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_head.
- NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_assertion description "[MET would be an important therapeutic antitumor target to be inhibited, and in lung cancer, MET may represent a cancer early progenitor cell marker.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_provenance.
- NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_assertion evidence source_evidence_literature NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_provenance.
- NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_assertion SIO_000772 18709663 NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_provenance.
- NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_assertion wasDerivedFrom befree-2016 NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_provenance.
- NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_assertion wasGeneratedBy ECO_0000203 NP688292.RAV9s5VhvPrlNElZxQ7evVsAQdFh7XqfjpPzhSgj4-NgA130_provenance.